Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'
- PMID: 21874125
- PMCID: PMC3160736
- DOI: 10.1002/ebch.786
Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'
Conflict of interest statement
References
-
- Reiersen AM, Todd RD. Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert review of neurotherapeutics. 2008 Apr;8(4):657–669. - PubMed
-
- Todd RD. Fluoxetine in autism. The American journal of psychiatry. 1991 Aug;148(8):1089. - PubMed
-
- Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. Journal of child and adolescent psychopharmacology. 2005 Feb;15(1):116–126. - PubMed
-
- Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005 Mar;30(3):582–589. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources